Clinical Trial Update: Regorafenib in Metastatic Colorectal Cancer : a Cohort Study in the Real-life Setting

View source ↗

Summary

This document provides an update on a real-world cohort study evaluating regorafenib in patients with metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Regorafenib (regorafenib)

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Metastatic Colorectal Cancer | Status: COMPLETED